US Stock MarketDetailed Quotes
ATXS Astria Therapeutics Inc
- 9.370
- -0.720-7.14%
Close Nov 15 16:00 ET
- 9.010
- -0.360-3.84%
Post 20:02 ET
528.79MMarket Cap-4298P/E (TTM)
10.170High9.110Low284.44KVolume10.170Open10.090Pre Close2.68MTurnover0.93%Turnover RatioLossP/E (Static)56.43MShares16.90052wk High2.15P/B286.86MFloat Cap4.40552wk Low--Dividend TTM30.61MShs Float1017.600Historical High--Div YieldTTM10.51%Amplitude2.360Historical Low9.432Avg Price1Lot Size
Astria Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -56.98%-16.79M | -44.07%-19.09M | -57.23%-68.45M | -183.55%-30.24M | -39.12%-14.26M | -6.31%-10.7M | -5.53%-13.25M | -44.38%-43.53M | -69.65%-10.66M | -32.26%-10.25M |
| Net income from continuing operations | -92.36%-24.17M | -78.12%-19.93M | -40.62%-72.89M | -136.82%-31.41M | -47.76%-17.73M | -11.69%-12.57M | 26.99%-11.19M | 73.41%-51.83M | -39.74%-13.26M | -52.42%-12M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 2,071.83%1.54M | --0 | --0 |
| Other non cash items | 389.12%944K | -541.38%-512K | 223.30%545K | 128.65%163K | 52.08%73K | 22.15%193K | 246.84%116K | -100.27%-442K | -198.44%-569K | 860.00%48K |
| Change In working capital | 1,171.53%5.49M | 58.60%-1.41M | -191.16%-2.41M | -150.60%-1.06M | 196.51%1.62M | 608.24%432K | -3,796.74%-3.4M | 168.27%2.65M | 65.09%2.1M | 142.64%545K |
| -Change in prepaid assets | 112.71%1.41M | -7.64%-930K | -189.92%-4.55M | -193.45%-3.23M | -61.13%-1.12M | 983.61%661K | -630.06%-864K | -1,944.71%-1.57M | -193.46%-1.1M | 66.91%-692K |
| -Change in payables and accrued expense | 5,508.97%4.22M | 86.75%-317K | -24.66%2.74M | -12.02%2.33M | 144.16%2.89M | 40.00%-78K | -4,171.43%-2.39M | 210.97%3.64M | 290.69%2.65M | 43.45%1.18M |
| -Change in other current liabilities | 12.58%-132K | -11.03%-161K | -206.27%-610K | -128.91%-159K | -381.82%-155K | -843.75%-151K | -866.67%-145K | 184.29%574K | --550K | --55K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -56.98%-16.79M | -44.07%-19.09M | -57.23%-68.45M | -183.55%-30.24M | -39.12%-14.26M | -6.31%-10.7M | -5.53%-13.25M | -44.38%-43.53M | -69.65%-10.66M | -32.26%-10.25M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -17.58%-68.1M | -164.74%-126.23M | 180.81%135.05M | 98.51%-2.02M | -100.21%-4K | -751.76%-57.92M | 819.55%194.99M | -1,231.17%-167.13M | -246.62%-135.18M | 1.95M |
| Net PPE purchase and sale | ---305K | --0 | 72.53%-25K | 48.39%-16K | 93.10%-4K | --0 | ---5K | -333.33%-91K | ---31K | ---58K |
| Net investment purchase and sale | -17.05%-67.8M | -164.73%-126.23M | 180.87%135.08M | 98.52%-2M | --0 | -752.02%-57.92M | 819.57%195M | -779.15%-167.04M | -246.54%-135.15M | --2.01M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -17.58%-68.1M | -164.74%-126.23M | 180.81%135.05M | 98.51%-2.02M | -100.21%-4K | -751.76%-57.92M | 819.55%194.99M | -1,231.17%-167.13M | -246.62%-135.18M | --1.95M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -65.57%94K | 383,162.16%141.81M | -38.92%88.4M | -26.93%87.98M | -99.55%110K | 273K | 37K | 38.78%144.72M | 708,117.65%120.4M | 405,300.00%24.32M |
| Net common stock issuance | --0 | --137.17M | -39.17%87.98M | -26.90%87.98M | --0 | --0 | --0 | 38.73%144.64M | --120.35M | ---- |
| Proceeds from stock option exercised by employees | -65.57%94K | 12,421.62%4.63M | 400.00%420K | --0 | 223.53%110K | --273K | --37K | 265.22%84K | 194.12%50K | --34K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -65.57%94K | 383,162.16%141.81M | -38.92%88.4M | -26.93%87.98M | -99.55%110K | --273K | --37K | 38.78%144.72M | 708,117.65%120.4M | 405,300.00%24.32M |
| Net cash flow | ||||||||||
| Beginning cash position | -14.96%172.18M | 749.25%175.69M | -76.12%20.69M | 160.04%119.97M | 345.44%134.12M | 331.04%202.46M | -76.12%20.69M | 245.81%86.63M | -65.02%46.14M | -78.44%30.11M |
| Current changes in cash | -24.08%-84.8M | -101.94%-3.52M | 335.07%155.01M | 318.98%55.72M | -188.31%-14.15M | -305.33%-68.34M | 558.36%181.78M | -207.09%-65.94M | 43.79%-25.45M | 306.96%16.03M |
| End cash Position | -34.85%87.38M | -14.96%172.18M | 749.25%175.69M | 749.25%175.69M | 160.04%119.97M | 345.44%134.12M | 331.04%202.46M | -76.12%20.69M | -76.12%20.69M | -65.02%46.14M |
| Free cash flow | -59.84%-17.1M | -44.02%-19.09M | -56.95%-68.47M | -182.88%-30.25M | -38.37%-14.26M | -6.29%-10.7M | -5.57%-13.26M | -44.58%-43.62M | -70.14%-10.7M | -33.01%-10.31M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data